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1. Introduction 
It will be shown in this paper that peripheral nerves 
do contain a protein similar to the glial fibrillary 
acidic protein (GFA), thus supporting the hypothesis 
that the protein subunits of glial and nerve filaments 
are alike [1,2]. The protein SO isolated, which we 
called SN1 protein, does not react with GFA antisera, 
but is related to GFA as indicated by comigration 
experiments on SDS-acrylamide g l electrophoresis, 
the type of degradation resulting from in situ proteo- 
lysis, amino acid composition and cyanogen bromide 
peptide mapping. 
GFA protein was originally identified as the con- 
stituent of astroglial fibers since it represents he 
major fraction in gliosed brain tissue and because 
fibrous astroglia re selectively stained in immuno- 
fluorescence t sts performed with diluted GFA anti- 
sera (reviewed in [3]). A recent comparative study 
of GFA purified from aqueous extracts of brain 
tissue and of the major protein contained in brain 
filaments isolated by density gradient centrifugation 
has shown that the two proteins have the same mol. 
wt. (54 000), and similar peptide maps [2]. The 
brain filaments were isolated from the axonal frac- 
tion [4] and thus presumably neurofilaments. How- 
ever, electron microscopic findings [4] and more 
recent work in this laboratory indicate that the 
axonal fraction also contains fibers which may be 
identified as glial, on the basis of their ultrastructural 
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features [4] and of positive immunofluorescence 
with GFA antisera [5]. The possibility could thus 
be considered that the protein similar to GFA con- 
tained in filaments isolated from axonal preparations 
was not related to neurofilaments but rather due to 
glial contamination, especially in view of the fact 
that electrophoretograms of axonal filaments in 
invertebrates donot show a major band in this 
molecular range [6,7]. 
In an attempt to solve this question - that is, 
whether glial and axonal filaments hare a similar 
protein subunit - we have applied to peripheral nerve 
extracts the procedure used in this laboratory to 
isolate GFA protein from aqueous extracts of normal 
brain [8], under the assumption that closely related 
proteins will follow the same purification procedure. 
Peripheral nerves do not contain astroglia, while the 
large myelinated axons are very rich in neurofilaments 
both in the central and peripheral nervous ystem. 
The purification of water-soluble proteins related to 
nerve and glial fibers may well represent a major 
advance in the biochemistry of a class of filaments 
7-10 nm in diameter which are particularly abundant 
in these structures and intermediate in size between 
microtubules and actin rnicrofilaments. I olated brain 
filaments are not soluble in aqueous olutions [4] 
and thus less amenable to biochemical studies. 
2. Materials and methods 
Rabbit sciatic nerves were purchased from Pel-Freez, 
Arkansas, and human sciatic nerves were dissected at 
autopsy. The time interval between death and autopsy 
North-Holland Publishing Company - Amsterdam 281 
Volume 66, number 2 FEBS LETTERS July 1976 
varied from 2 to 24 h. Human liver, kidney, testis and 
serum were also used to control the specificity of the 
purification procedure. From none of these a protein 
migrating in the GFA range on SDS-acrylamide g l 
electrophoresis was isolated. The tissue homogenates 
were extracted with 0.05 M sodium phosphate buffer, 
pH 8.0. The extracts were adsorbed to hydroxylapatite 
in the same buffer and protein was eluted with 0.1 M 
potassium phosphate buffer, pH 8.0, after all unadsorb- 
ed protein had been removed by extensive washing 
with 0.05 M sodium phosphate buffer, pH 8.0. The 
eluates were pooled and precipitated by adding 
ammonium sulfate to a final concentration f 30%. 
The ammonium sulfate precipitates were resuspended 
in 0.05 M sodium phosphate buffer, pH 8.0, dialyzed 
against water and freeze-dried. In some experiments 
the sediments were redissolved with 0.05 M sodium 
phosphate buffer, pH 8.0, and the protein was 
precipitated by adding sodium acetate pH 4.7 dropwise 
while stirring. SNI protein started to precipitate at 
pH 6.4 and, as GFA protein [9] was completely 
precipitated atpH 5.0. Both proteins were redissolved 
at lower and higher pH. In other experiments peripheral 
nerves were first extracted with 0.01 M sodium 
phosphate-MgC12 buffer pH 6.2, a buffer used to 
solubilize tubulin [10], and then with 0.05 M sodium 
phosphate buffer pH 8.0. Both extracts were adsorbed 
to hydroxylapatite n sodium phosphate buffer, 
pH 8.0, and the procedure was continued as described 
before. Most of the SN1 protein was present in the 
pH 8.0 extract, thus showing that the differential 
solubility in buffer solutions [9] was another com- 
mon proterty of SN~ and GFA proteins. 
3. Results and discussion 
SNI protein isolated from rabbit sciatic nerves 
yielded a single band on SDS gel electrophoresis at 
5%, 7.5% and 12.5% acrylamide concentration 
(fig.l, gel 1), co-migrating with GFA protein, 54 000 
daltons [8], in mixing experiments. SN1 protein 
isolated from human sciatic nerves howed a multiple 
band pattern suggestive of degradation [8,11 ] (fig. 1, 
gel 3). As previously described for GFA protein from 
human, bovine and rat brain [8,11 ], a marked 
enrichment in the lower mol. wt. species was obtained 
by incubating sciatic nerves at 24°C for 24-48 h. 
After 72 h only polypeptide co-migrating with 
highly degraded GFA protein, 45 000 - 40 500 mol. 
wt. [11 ] were present. The preparations u ed for 
amino acid analysis (table 1) were isolated from 
sciatic nerves dissected shortly after death and 
showing little degradation. 
Reduced and non-reduced preparations ofSN1 
protein had markedly different electrophoretic 
mobility on SDS gels. As observed with GFA protein 
(Dahl and Bignami, in preparation), without 
dithiothreitol in the sample nondegraded protein 
stayed at the origin of the gel (fig. 1, gel 2). With 
degraded protein, the lower mol. wt. components were 
selectively included into the gel (fig.l, gel 4). The 
Fig.1. SDS gel electrophoresis at 7.5% acrylamide concentra- 
tion [18] of reduced and non-reduced SNt protein. Gel 1, 
reduced rabbit SN 1 protein migrates a  a single band at 
54 000 daltons; gel 2, the same protein as in gel 1 without 
dithiothreitol inthe electrophoretic sample. Most of the 
protein stays on the top of the gel. Comparable r sults were 
obtained with non-reduced GFA protein; gel 3, red uced 
human SN1 protein isolated from sciatic nerves dissected 
24 h after death. Arrowheads indicate contaminants (purifica- 
tion was less complete with autolyzed tissue); gel 4, the same 
protein as in gel 3 without dithiothreitol inthe electrophoretic 
sample. Degraded protein is selectively included into the gel. 
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Table 1 
Amino acid analysis of SN t and GFA proteins 
Amino acid SN~ protein GFA 
Human a Rabbit Human a Bovine 
(4) (4) (2) (2) 
moles % 
Lysine 5.7 5.3 6.1 4.4 
Histidine 2.1 1.9 2.2 2.3 
Arginine 5.9 5.4 4.8 5.7 
Cysteine b 1.4 nd c nd c 1.5 
Aspartic acid 10.9 10.5 10.7 10.3 
Threonine 5.1 5.6 6.0 5.8 
Serine 6.4 7.0 6.3 6.2 
Glutamic acid 16.3 15.2 16.5 15.0 
Proline 4.4 5.2 4.1 4.9 
Glycine 8.4 11.4 9.4 7.5 
Alanine 7.7 8.4 8.6 8.5 
Valine 5.1 5.1 5.9 5.7 
Methionine 2.0 2.3 2.5 2.6 
Isoleucine 3.8 3.4 3.7 3.8 
Leucine 9.4 7.9 8.4 8.6 
Tyrosine 2.7 2.8 2.1 3.2 
Phenylalanine 3.1 3.0 2.7 3.9 
Average of 24 and 72 h hydrolysates. Number of determinations i  parentheses. 




effect of reducing agents may be explained by recent 
studies indicating that the 54 000 polypeptide chains 
of GFA protein are covalently assembled into large 
polymers by interchain disulfide bridges [12]. The 
selective inclusion of degraded protein into the gels 
suggests that cleavage occurs in the region of the 
molecule containing the intermolecular disulfide 
bridges and that the 45 000 - 40 500 degraded species 
are not covalently linked. 
The effect of reducing agents on the rnol. wt. of 
non-degraded SN1 and GFA proteins is of interest 
considering that the amino acid composition of these 
proteins (table 1) is very similar to tubulin [ 10,13 ]. 
In agreement with literature data [13], we did not 
observed marked differences in the electrophoretic 
mobility on SDS gels between reduced and non- 
reduced tubulin. Disulfide bonds, if present in tubulin, 
appear to be intramolecular rather than intermolecular 
[14]. Further evidence that our preparations are not 
contaminated by tubulin is provided by the fact that 
the amino terminal amino acid of non-degraded GFA 
protein is blocked [15], while both the alpha and 
beta subunits of tubulin have methionine as the amino 
terminal residue [13]. 
The cyanogen bromide peptide maps of highly 
degraded GFA protein from multiple sclerosis plaque s 
[11 ], bovine GFA, and human SN1 protein are 
shown in fig.2. A 17 000 tool. wt. peptide was 
common to all preparations. 
The isolation of a protein similar to GFA from 
peripheral nerve but not reacting with GFA antisera, 
with the same procedure to purify GFA from the 
brain, raises a major question, i.e., whether both glial 
and nerve fibers are the source of the protein isolated 
from normal brain. The apparent selectivity of the 
antisera for the astroglial component could be 
explained with the fact that the original preparations 
used as antigen were isolated from tissue selectively 
enriched in glial fibers (multiple sclerosis plaques) 
[16,17]. However, we have recently prepared antisera 
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Fig.2. Cyanogen bromide peptides of SN 1 and GFA proteins 
on SDS/urea gel electrophoresis [19]. A cyanogen bromide 
peptide migrating in the myoglobin range 17 200 tool. wt. is 
common to all preparations. Slower migrating bands are 
probably the result of aggregation since they were not 
observed on SDS gel electrophoresis. Gel 1, incomplete digest 
of myoglobin used as the standard [19]: (a) myoglobin, 
17 200; (b) peptides I + II, 14 900; (c) peptide I, 8270; (d) 
peptide II, 6420; (e) peptide III, 2550; gel 2, digest GFA 
protein isolated from gliosed human brain [11 ] ; gel 3, digest 
of bovine GFA protein; gel 4, digest of human SN~ protein; 
gel 5, cyanogen bromide peptide in the myoglobin range 
isolated from the digest of bovine GFA protein by hydroxyl- 
apatite chromatography. 
with the same specificity using GFA protein isolated 
from normal spinal cord (Dahl and Bignami, in prepara- 
tion), thus suggesting that if the glial and neuronal 
components are isolated in the same fraction, they 
differ markedly in immunogenicity. 
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